Skip to main content

Table 2 Number of trials recording adverse events by type of treatment

From: The challenges of long-term follow-up data collection in non-commercial, academically-led breast cancer clinical trials: the UK perspective

  Chemotherapy Endocrine therapy Radiotherapy Neoadjuvant/perioperative therapy Other All
Cardiovascular 3 (38%) 4 (50%)* 5 (71%)* 0 (0%) 2 (33%) 14 (41%)
Neurological 1 (13%) 2 (25%) 0 (0%) 0 (0%) 2 (33%) 5 (15%)
Menopausal 0 (0%) 3 (38%) 0 (0%) 0 (0%) 0 (0%) 3 (9%)
Fracture 1 (13%) 4 (50%)* 5 (71%)* 0 (0%) 1 (17%) 11 (32%)
Other musculoskeletal 1 (13%) 4 (50%)* 2 (29%) 0 (0%) 0 (0%) 7 (21%)
Psychiatric 0 (0%) 2 (25%) 0 (0%) 0 (0%) 0 (0%) 2 (6%)
Gastrointestinal 0 (0%) 3 (38%) 0 (0%) 0 (0%) 0 (0%) 3 (9%)
Gynaecological 0 (0%) 4 (50%)* 0 (0%) 0 (0%) 0 (0%) 4 (12%)
Other (free text) 6 (75%)* 6 (75%)* 5 (71%)* 3 (60%)* 4 (67%)* 24 (71%)*
Hospitalisations (free text) 3 (38%) 2 (25%) 0 (0%) 0 (0%) 2 (33%) 7 (21%)
  1. *Greater than or equal to 50% of trials requested details.